To Evaluate the Efficacy of Vidangadi Gutika in Mutrashmari With Special Reference to Urolithiasis

A RANDOMIZED OPEN CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF VIDANGADI GUTIKA IN THE MANAGEMENT OF MUTRASHMARI WITH SPECIAL REFERENCE TO UROLITHIASIS - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108459

Enrollment

Registered

2026-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient with clinical features and USG showing ureteric,kidney,bladder calculus of size from 2 mm to 6 mm single or multiple or bilateral calculus will be taken for treatment. 2)Patients presenting below mentioned signs and symptoms of Ashmari :Regional pain (Nabhi,Basti,Sevani,Mehana Vedana) 3)Subjects of the age in between 20-60 years. 4)The patient will be selected irrespective of gender,religion,occupation,marital status. 5)Patient with controlled DM and HTN.

Exclusion criteria

Exclusion criteria: A) Known case of: 1)Pt of shukrashmari. 2)Pt having renal failure 3)Pt suffering -HIV,HbsAg,HCV,TB 4)Pt with sever redness and gross hematuria more than grade3 or 4. 5)Pt with uncontrolled:DM,HTN 6)Urine retention-acute or chronic 7)Severe hydronephrosis,hydroureter 8)Parathyroidism 9)Pyelonephritis 10)BPH 11)Any malignancy B)Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
To Evaluate the Efficacy of Vidangadi Gutika in Mutrashmari and to find out whether it reduces the size of Mutrashmari With Special Reference to Urolithiasis.Timepoint: 15 days	—

Secondary

Measure	Time frame
1)To find out whether this drug reduces the size of Mutrashmari or promotes its expulsion in comparison with Tab cystone. 2)To study the probable mode of action of Vidangadi gutika for 15 days. 3)To find out whether this drug reduces the symptoms of pain,burning micturition of Mutrashmari. 4)To achieve the outcome of study within 15 days.Timepoint: 15 days	—

Countries

India

Contacts

Public ContactADITI YASHWANT SULE

Yashwant Ayurvedic college Post Graduate Traning and Research Centre Kodoli

drsrinivast@gmail.com9503147698

Outcome results